Going alone, though possible I think is still a less preferable option to the Board, licensing would still be the preferred.
Phase 3 and getting to manufacturing/Commercialisation is expensive.
That being said, becoming a drug company with our own working product(s) would be more valuable in the long run.
Lots of dollars and time needed to get there.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $89.60M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $536.1K | 43.65M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 7849799 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 5438256 | 28 |
View Market Depth
| Last trade - 14.25pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |